ArticleThe World Allergy Organization journal2026
Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study.
Maoying Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.